297 related articles for article (PubMed ID: 20195368)
1. Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.
Patel BP; Safdar A; Raha S; Tarnopolsky MA; Hamadeh MJ
PLoS One; 2010 Feb; 5(2):e9386. PubMed ID: 20195368
[TBL] [Abstract][Full Text] [Related]
2. Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice.
Hamadeh MJ; Tarnopolsky MA
Muscle Nerve; 2006 Dec; 34(6):709-19. PubMed ID: 16941656
[TBL] [Abstract][Full Text] [Related]
3. Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse.
Hamadeh MJ; Rodriguez MC; Kaczor JJ; Tarnopolsky MA
Muscle Nerve; 2005 Feb; 31(2):214-20. PubMed ID: 15625688
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice.
Kirkinezos IG; Bacman SR; Hernandez D; Oca-Cossio J; Arias LJ; Perez-Pinzon MA; Bradley WG; Moraes CT
J Neurosci; 2005 Jan; 25(1):164-72. PubMed ID: 15634778
[TBL] [Abstract][Full Text] [Related]
5. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
[TBL] [Abstract][Full Text] [Related]
6. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
7. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
Zhao Z; Sui Y; Gao W; Cai B; Fan D
J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
[TBL] [Abstract][Full Text] [Related]
8. Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis.
Moghimi E; Solomon JA; Gianforcaro A; Hamadeh MJ
PLoS One; 2015; 10(5):e0126355. PubMed ID: 26020962
[TBL] [Abstract][Full Text] [Related]
9. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Andrus PK; Fleck TJ; Gurney ME; Hall ED
J Neurochem; 1998 Nov; 71(5):2041-8. PubMed ID: 9798929
[TBL] [Abstract][Full Text] [Related]
10. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
11. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
12. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
Golko-Perez S; Mandel S; Amit T; Kupershmidt L; Youdim MB; Weinreb O
Neurotox Res; 2016 Feb; 29(2):208-17. PubMed ID: 26581376
[TBL] [Abstract][Full Text] [Related]
13. Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis.
Miana-Mena FJ; González-Mingot C; Larrodé P; Muñoz MJ; Oliván S; Fuentes-Broto L; Martínez-Ballarín E; Reiter RJ; Osta R; García JJ
J Neurol; 2011 May; 258(5):762-9. PubMed ID: 21108037
[TBL] [Abstract][Full Text] [Related]
14. Swim Training Modulates Mouse Skeletal Muscle Energy Metabolism and Ameliorates Reduction in Grip Strength in a Mouse Model of Amyotrophic Lateral Sclerosis.
Flis DJ; Dzik K; Kaczor JJ; Cieminski K; Halon-Golabek M; Antosiewicz J; Wieckowski MR; Ziolkowski W
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634386
[TBL] [Abstract][Full Text] [Related]
15. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector.
Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C
Brain Res Bull; 2019 Jan; 144():1-13. PubMed ID: 30414993
[TBL] [Abstract][Full Text] [Related]
16. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
17. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
Martin LJ; Liu Z; Chen K; Price AC; Pan Y; Swaby JA; Golden WC
J Comp Neurol; 2007 Jan; 500(1):20-46. PubMed ID: 17099894
[TBL] [Abstract][Full Text] [Related]
18. Suppression of apoptosis by calorie restriction in aged kidney.
Lee JH; Jung KJ; Kim JW; Kim HJ; Yu BP; Chung HY
Exp Gerontol; 2004 Sep; 39(9):1361-8. PubMed ID: 15489059
[TBL] [Abstract][Full Text] [Related]
19. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
